GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gilead Sciences GILD · USD

Health Care · Biotechnology · US listing · 🇺🇸 United States

S&P 500Nasdaq-100

Compare

169.32

+1.46%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Gilead Sciences

Our reporting

Next results

9 Feb 2027

Due on 9 Feb 2027. Analysts expect earnings of 1.39 a share on revenue of $8.28bn.

Past results

Reported against what analysts expected

29 Oct 20263 Aug 20267 May 202610 Feb 202630 Oct 20257 Aug 2025
Earnings per share2.55-6.752.031.862.472.01
Forecast2.19-7.251.911.812.131.96
Revenue$8.30bn$7.80bn$6.96bn$7.92bn$7.77bn$7.08bn
Forecast$7.81bn$7.40bn$6.91bn$7.69bn$7.45bn$6.98bn

Key events

  1. 28 Jan 20132-for-1 share split
  2. 25 Jun 20072-for-1 share split
  3. 7 Sept 20042-for-1 share split
  4. 8 Mar 20022-for-1 share split
  5. 22 Feb 20012-for-1 share split
  6. 1 Jan 1992Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.